Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Prostaglandins Leukot Essent Fatty Acids. 2023 Jan 26;190:102542. doi: 10.1016/j.plefa.2023.102542

TABLE 1.

Characteristics of participants with rheumatoid arthritis and matched controls without rheumatoid arthritis from the Mass General Brigham Biobank

Parameter Rheumatoid Arthritis Cases (n=52) Non-Rheumatoid Arthritis Matched Controls (n=52) P value*
Matching Factors
Age at blood draw (mean, SD) 50.0 (7.37) 49.5 (7.35) 0.73
Female, n (%) 44 (84.6) 44 (84.6) 1.00
Race 0.27
-White, n (%) 47 (90.4) 48 (92.3)
-Non-White, n (%) 5 (9.6) 2 (3.9)
Smoking Status 0.35
-Never, n (%) 33 (63.5) 34 (65.4)
-Past, n (%) 17 (32.7) 12 (23.1)
-Current, n (%) 2 (3.9) 4 (7.7)
Other Covariates
Body mass index kg/m2 (mean, SD) 29.8 (10.42) 26.0 (4.54) 0.02
Taking a statin medication, n (%) 6 (11.5) 4 (7.7) 0.74
Characteristics of Rheumatoid Arthritis cases
Rheumatoid factor positive, n (%) 26 (50.0)
Anti-CCP positive, n (%) 15 (28.9)
Elevated ESR or CRP, n (%) 24 (46.2)
Taking steroid, n (%) 8 (15.4)
Taking immunosuppressant, n (%) 43 (82.7)

Chi squared test for categorical values and t-test for continuous variables. N: number; SD: standard deviation; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; anti-CCP: anti-cyclic citrullinated peptide; Race data missing in 2 matched controls without RA. Smoking status missing in 2 matched controls without RA ESR or CCRP missing in 3 patients with RA